Letrozole Tablets trials for Breast cancer

All Letrozole Tablets trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Letrozole Tablets for Breast cancer

• A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer
  NCT06974929 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
• A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer
  NCT07024173 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer
  NCT07349069 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer
  NCT07389733 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations

Common questions

How many trials study Letrozole Tablets for Breast cancer?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.